Journal Home
Search for

Volume 15, Issue 5, Pages 378-385 (15 May 2008)


View previous. 11 of 13 View next.

Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis

Taofikat B. AgbabiakaCorresponding Author Informationemail address, Ruoling Guo, Edzard Ernst

Refers to erratum:
Erratum to “Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis” [Phytomedicine 15 (2008) 378–385]
Taofikat B. Agbabiaka, Ruoling Guo, Edzard Ernst
Phytomedicine
August 2009 (Vol. 16, Issue 8, Pages 798-799)
Full Text | Full-Text PDF (120 KB)

Abstract 

Objective

To critically assess the efficacy of Pelargonium sidoides for treating acute bronchitis.

Data sources

Systematic literature searches were performed in 5 electronic databases: (Medline (1950 – July 2007), Amed (1985 – July 2007), Embase (1974 – July 2007), CINAHL (1982 – July 2007), and The Cochrane Library (Issue 3, 2007) without language restrictions. Reference lists of retrieved articles were searched, and manufacturers contacted for published and unpublished materials.

Review methods

Study selection was done according to predefined criteria. All randomized clinical trials (RCTs) testing P. sidoides extracts (mono preparations) against placebo or standard treatment in patients with acute bronchitis and assessing clinically relevant outcomes were included. Two reviewers independently selected studies, extracted and validated relevant data. Methodological quality was evaluated using the Jadad score. Meta-analysis was performed using a fixed-effect model for continuous data, reported as weighted mean difference with 95% confidence intervals.

Results

Six RCTs met the inclusion criteria, of which 4 were suitable for statistical pooling. Methodological quality of most trials was good. One study compared an extract of P. sidoides, EPs®7630, against conventional non-antibiotic treatment (acetylcysteine); the other five studies tested EPs®7630 against placebo. All RCTs reported findings suggesting the effectiveness of P. sidoides in treating acute bronchitis. Meta-analysis of the four placebo-controlled RCTs suggested that EPs®7630 significantly reduced bronchitis symptom scores in patients with acute bronchitis by day 7. No serious adverse events were reported.

Conclusion

There is encouraging evidence from currently available data that P. sidoides is effective compared to placebo for patients with acute bronchitis.

Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK

Corresponding Author InformationCorresponding author. Tel.: +441392424942; fax: +441392427562.

PII: S0944-7113(07)00307-8

doi:10.1016/j.phymed.2007.11.023


View previous. 11 of 13 View next.